Secondary Logo

Journal Logo

AAPA Members can view Full text articles for FREE. Not a Member? Join today!

Institutional members access full text with Ovid®

Using buprenorphine to treat patients with opioid use disorder

Radi, Joshua K. PhD, PA-C; Fogarty, Kieran J. PhD; Lagerwey, Mary D. PhD, RN

Journal of the American Academy of PAs: October 2019 - Volume 32 - Issue 10 - p 30–35
doi: 10.1097/01.JAA.0000580544.64346.d7
Review Article

ABSTRACT The US opioid epidemic is a complex problem that has resulted in legislative actions to make treatment more accessible to patients. Physician assistants (PAs) have taken an active role in expanding their scope of practice to keep up with treatment needs. This article describes opioid use disorder in the United States, treatment gaps, safe treatment with buprenorphine, and PA prescriptive authority.

Joshua K. Radi is a physician assistant in the Hawaii Army National Guard's Weapons of Mass Destruction-Civil Support Team in Kapolei, Hawaii, and in the Department of Orthopedic Surgery at Tripler Army Medical Center. He also is a clinical educator in the University of Hawaii's Department of Surgery in Honolulu. Kieran J. Fogarty is director of the Interdisciplinary Health Sciences doctoral program at Western Michigan University in Kalamazoo, Mich. Mary D. Lagerwey is director of Western Michigan University's Bronson School of Nursing. The authors have disclosed no potential conflicts of interest, financial or otherwise. The views/opinions expressed are those of the authors and do not necessarily represent the views of the Department of the Army and/or the Department of Defense.

Acknowledgments: The authors would like to thank Patrick Knott, PhD, PA-C, and Jim Anderson, PA-C, MPAS, DFAAPA, for their assistance with this manuscript.

Copyright © 2019 American Academy of Physician Assistants
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website